Understanding Systemic Lupus Erythematosus

Lupus (Systemic Lupus Erythematosus, abbreviated SLE) is a chronic autoimmune disease characterized by an overactive immune system that mistakenly attacks its own tissues as if they were foreign invaders. This disease can affect multiple organ systems including the skin, joints, and internal organs, presenting a variety of symptoms. The pathogenesis of lupus is complex and involves interactions between genetic, environmental, and hormonal factors, thus requiring a multidisciplinary medical team for diagnosis and treatment.

In recent years, the medical community's understanding of lupus has deepened, with new treatment methods and management strategies continuously developing. If patients can be diagnosed early and receive personalized treatment, they can effectively control the disease and delay organ damage. This article will comprehensively analyze information related to lupus from multiple perspectives, including causes, symptoms, diagnosis, treatment, and prevention, to help readers build an overall understanding of this disease.

Causes and Risk Factors

The exact causes of lupus are not fully understood, but it is known to result from the combined effects of genetic, environmental, and immune system abnormalities. In terms of genetic predisposition, certain gene polymorphisms (such as HLA gene groups) increase the risk of developing the disease, but a single gene defect does not directly cause the disease; environmental triggers are usually required. Environmental factors include ultraviolet exposure, infections, specific medications (such as anticonvulsants), or stress events, which may trigger immune system dysregulation.

Hormonal factors play a key role in the development of lupus, with female patients having higher estrogen levels accounting for up to 90% of cases, which aligns with the phenomenon of more female patients than male. Additionally, abnormalities in T cell and B cell functions within the immune system lead to the overproduction of autoantibodies such as antinuclear antibodies (ANA), which in turn cause tissue inflammation. Research shows that epigenetic changes (such as DNA methylation) may regulate gene expression and affect immune dysregulation.

  • Genetic Factors: A family history is an important risk indicator, with first-degree relatives having a 10-fold higher risk than the general population.
  • Environmental Triggers: Sun exposure, infections (such as EB virus), and specific medications may induce flares.
  • Hormonal Influence

Symptoms

The symptoms of lupus are diverse and variable, often referred to as a "chameleon disease." Typical symptoms include a facial butterfly rash (photosensitive rash), joint pain, and swelling. About 80% of patients will experience skin symptoms, with "lupus malar rash" being a common skin indicator. Systemic symptoms may include prolonged fever, weight loss, and fatigue, the latter often underestimated but severely impacting quality of life.

Organ involvement varies from person to person and may affect the kidneys (proteinuria, renal failure), lungs (pleuritis), cardiovascular system (pericarditis), and central nervous system (headaches, seizures). Some patients may experience a "lupus crisis," which is an acute multi-system exacerbation and is a medical emergency requiring immediate intervention. Symptoms may present in a cyclical pattern of flares and remissions, complicating diagnosis.

  • Skin: Photosensitive rash, discoid lupus erythematosus, fingertip ulcers.
  • Joints and Muscles: Non-destructive arthritis, muscle pain.
  • Internal Organs: Nephritis, pericarditis, neurological abnormalities.
  • Systemic Symptoms: Persistent fatigue, fever, lymphadenopathy.

Diagnosis

The diagnosis of lupus requires a comprehensive assessment of clinical manifestations, laboratory tests, and classification criteria. The classification criteria developed jointly by the American College of Rheumatology and the European League Against Rheumatism include 11 clinical and immunological indicators. Common diagnostic procedures include:

  1. Detailed history taking: Tracking the timeline of symptoms, family history, and medication use.
  2. Blood tests: Antinuclear antibody (ANA) testing serves as a screening test, with a positivity rate exceeding 95%.
  3. Specialized immunological tests: Indicators such as anti-dsDNA antibodies and anti-Sm antibodies.
  4. Imaging and tissue biopsy: Renal ultrasound or kidney biopsy to confirm the degree of nephritis.

The diagnostic challenge lies in the symptoms being easily confused with other autoimmune diseases, such as rheumatoid arthritis or Sjögren's syndrome. Physicians must rule out other possible diagnoses and track disease progression to confirm diagnostic accuracy. The updated classification criteria in 2019 added quantitative standards for immunological indicators, enhancing diagnostic precision.

Phased Diagnostic Process

Initial screening: After a positive ANA test, further testing for anti-double-stranded DNA antibodies (anti-dsDNA) and complement levels is conducted.

Treatment Options

The goal of lupus treatment is to control the activity of the immune system, relieve symptoms, and prevent organ damage. Treatment strategies are divided into basic treatment and management during exacerbations based on disease severity. Common medications include:

  • Non-steroidal anti-inflammatory drugs (NSAIDs): Used for mild joint pain and inflammation.
  • Immunosuppressants: Such as methotrexate for moderate to severe cases.
  • Biologics: Such as belimumab targeting specific immune pathways.

New treatment strategies include JAK inhibitors and targeted B-cell therapies, which can reduce the side effects of traditional immunosuppressants. Patients need regular monitoring of blood counts, liver and kidney function, and signs of infection, as the treatment itself may pose risks related to immunosuppression.

Long-term Management Strategies

Patients should establish a personalized treatment plan that combines medication with lifestyle adjustments. Regular follow-up items include:

  1. Checking antinuclear antibody levels every 3-6 months.
  2. Conducting urine analysis and kidney function tests every six months.
  3. Annual ophthalmologic examinations to monitor for ocular complications.

Prevention

Although lupus cannot be completely prevented, the following measures can reduce the frequency and severity of flares:

  • Avoiding ultraviolet exposure: Using SPF 50+ sunscreen and wearing UV-protective clothing.
  • Vaccination: Receiving pneumococcal and influenza vaccines during stable periods of the disease.
  • Stress management: Mindfulness meditation and regular exercise can regulate immune responses.

In terms of nutrition, a high-fiber diet is recommended, limiting processed foods, and supplementing vitamin D under physician supervision. Avoiding known triggers such as certain medications or sources of infection can help maintain disease stability.

Special Considerations for High-Risk Groups

Women of childbearing age need to pay special attention to pregnancy management, as pregnancy may induce disease activity. It is recommended to achieve a state of remission 6 months prior to planning pregnancy, with monitoring by both rheumatologists and obstetricians.

When Should You See a Doctor?

Seek medical attention immediately if the following symptoms occur:

  • Newly developed skin rash accompanied by fever and joint swelling.
  • Darkening of urine color or foamy urine without known cause.
  • Chest pain accompanied by difficulty breathing or palpitations.

Chronic symptom exacerbation (such as worsening fatigue or persistent joint swelling lasting more than six weeks) should also prompt early medical consultation. Even during periods of remission, it is advisable to have specialist follow-ups every 3-6 months to monitor for potential organ damage.

Emergency Indicators

If the following emergency symptoms occur, immediate emergency care is needed:

  • Confusion or seizures.
  • Severe difficulty breathing accompanied by cyanosis.
  • Significant decrease in urine output with severe lower limb edema.

Early diagnosis and treatment can significantly improve prognosis, and patients should establish a long-term cooperative relationship with their healthcare team, regularly assessing treatment responses and managing side effects.

 

Frequently Asked Questions

How should patients with lupus protect their skin from UV damage in daily life?

Patients should use broad-spectrum sunscreen with SPF 50+ or higher, combined with physical barriers such as long-sleeved clothing and wide-brimmed hats. Avoid going out during peak sunlight hours, and if prolonged outdoor exposure is necessary, it is advisable to use UV-protective umbrellas. If there are lesions on the skin, medications should be used as prescribed and chemical irritants should be avoided.

Can patients with lupus receive vaccinations during treatment? What should be noted?

Most vaccines can be administered, but it depends on the disease activity and medication adjustments. For example, live virus vaccines (such as measles and chickenpox) should be given when the disease is stable and high-dose steroids are not being used. It is advisable to consult a specialist before vaccination and inform them of the current medication list to reduce the risk of infections or drug interactions.

When symptoms of lupus flare up, how can one determine if treatment adjustments are necessary?

If new symptoms occur (such as unexplained fever, worsening joint swelling, or spreading skin lesions) or existing symptoms severely impact daily life, medical evaluation should be sought immediately. Physicians may decide to adjust the dosage of immunosuppressants or biologics based on blood tests (such as anti-double-stranded DNA antibodies, C3/C4 complement levels) or imaging studies.

What foods or ingredients should patients avoid in their daily diet that may trigger disease exacerbation?

Currently, there is no specific list of forbidden foods, but foods high in alginates (such as kelp) and photosensitive foods (such as figs and celery) may trigger photosensitivity symptoms in some patients. It is advisable to keep a record of dietary intake and symptom correlations. Additionally, long-term steroid users should be mindful of low sodium and low calcium diets, and supplement calcium and vitamin D as prescribed to prevent osteoporosis.

What effective strategies for managing emotional stress have been proven for patients with lupus?

Mindfulness meditation and regular exercise have been clinically proven to effectively alleviate stress hormone levels in chronic disease patients. It is recommended to practice deep breathing exercises for 10-15 minutes daily and incorporate moderate aerobic activities such as swimming. Joining patient support groups for experience sharing can also reduce feelings of isolation, but it is important to avoid overly exhausting social activities.

Lupus